Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs, such as lovastatin, may protect normal cells from the side effects of
radiation therapy.
PURPOSE: This phase II trial is studying how well lovastatin works in reducing side effects
after radiation therapy in women with breast cancer.